Yseop: Difference between revisions

Content deleted Content added

Inline

Revision as of 11:07, 27 May 2024

Yseop (pronounced 'Easy-Op') is a software company and a leader in Generative AI for life science and pharmaceutical companies, changing the way content automation solutions are delivered with a human-centric, AI platform. Yseop is a pioneer in Natural Language Processing (NLP) technology and acts as a “Copilot” for medical writers, maximizing their efficiency and accuracy in generating reports and insights crucial to drug development and approval. With cutting-edge language models, Yseop ensures today’s biopharmaceutical companies are meeting the most demanding content tasks with ease, scalability and application security.

As the world’s leading content automation solution for pharmaceuticals, Yseop Copilot is a digital colleague that empowers scientific writers and addresses the unique requirements of the highly regulated pharmaceutical industry. Blending the power of language models with customer data, Yseop Copilot delivers trusted and auditable content automation solutions in a closed, secure environment.

With offices in Paris, New York and Lyon, the company has been at the forefront of the technological innovation that is reshaping regulated industries through Generative AI and automation.

The Yseop Team

At the heart of Yseop's success is its dedicated team of professionals, including linguists and AI specialists. Led by CEO Emmanuel Walckenaer, the company is committed to promoting gender equality and diversity within its workforce. Yseop fosters a culture of innovation and collaboration, with a focus on delivering exceptional value to customers. Alain Kaeser, Yseop's founder, continues to lead its strategic planning.

Products

Yseop launched Yseop Copilot, the world’s most secure content automation solution for regulated industries. Yseop Copilot is an enterprise software platform leveraging pre-trained LLM models for the BioPharma industry. The multimodal platform is a massive leap forward for life sciences firms looking to address their automation requirements and empowers scientific writers to be more strategic and productive with their resources in a closed, secure environment.

Yseop Copilot supercharges productivity and keeps scientific writing in-house for quality control. With Yseop Copilot, scientific writers across hundreds of clinical trials have slashed writing times and improved the consistency and reliability of reports in record time. Yseop built this digital solution specifically for regulated industries like BioPharma, as proprietary prompts and validation methods ensure writing accuracy, while citations preserve traceability.

Yseop Copilot is hosted in a fully secure, private environment for each customer. The multimodal platform leverages a variety of data-to-text (symbolic AI) and text-to-text (pre-trained open source LLM) techniques for the most cohesive and intelligent content automation process available to regulated industries today. GxP compliant with full auditability, users have control and pre-configured settings available for use right away. Yseop Copilot solves critical data security concerns and enables a high fidelity automation for non-clinical and clinical documents.

Recognitions

Yseop's dedication to innovation and customer satisfaction has earned it numerous accolades, including recognition from ChooseMyCompany for workplace happiness and motivation. The company is proud to be positioned in the Top 10 HappyIndex®AtWork for Startups + 50 employees in 2021, reflecting the enthusiasm and pride of its employees in democratizing NLG technology.

Yseop has since garnered significant recognition for its innovative contributions, winning prestigious awards and earning nominations across multiple categories. Among these achievements, Yseop has been honored as a winner and finalist in various esteemed competitions.

In 2023:

Listed in The Top 10 natural language generation Companies in 2023 alongside Google and Open AI.
Shortlisted for Global Business Tech Awards as Tech Company of the Year in 2023. Yseop has been honored as a finalist as the Global Business Tech Awards showcase the best tech from around the world.
Nominated for World Technology Leader Awards. Yseop was in the company of prestigious nominees including OpenAI, BMW, and BASF. This award recognizes technology excellence across all industries and countries.
Winner at 2023 Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials. By winning Yseop platform “Yseop Copilot” has been recognized as a leading Generative AI solution, revolutionizing and improving drug discovery, clinical development, and the commercial adoption of new medicines.

In 2024:

Shortlisted for Business Intelligence Group’s Artificial Intelligence Excellence Awards in 2024. Yseop has been honored as a where the award identifies and recognizes the truly unique solutions that stand out in a crowded artificial intelligence space.
Back-to-Back Finalists at Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials in 2024. has been named as a finalist for the second consecutive year at the 2024 Citeline Awards in the category of Best Use of Artificial Intelligence in Clinical Trials.

Yseop Podcast: AI Uncovered

AI Uncovered is a podcast presented by Yseop for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries.

With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across biopharmaceutical organizations. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.

References

External links

Official website

@@ Line 1: / Line 1: @@
 {{Short description|French software company}}
 {{Notability|1=Companies|date=October 2022}}
+'''Yseop''' (pronounced 'Easy-Op') is a software company and a leader in Generative AI for life science and pharmaceutical companies, changing the way content automation solutions are delivered with a human-centric, AI platform. Yseop is a pioneer in Natural Language Processing (NLP) technology and acts as a “Copilot” for medical writers, maximizing their efficiency and accuracy in generating reports and insights crucial to drug development and approval. With cutting-edge language models, Yseop ensures today’s biopharmaceutical companies are meeting the most demanding content tasks with ease, scalability and application security.
-'''Yseop''' (pronounced 'Easy-Op') is a French software company, specializing in [[No-code development platform|no code]] intelligent report automation, using [[natural language generation]] (NLG). Established in 2000 with offices in Paris,<ref name=":0">{{Cite web|url=https://www.lesechos.fr/2012/04/les-logiciels-dyseop-ecrivent-pour-la-societe-generale-355124|title=Les logiciels d'Yseop écrivent pour la Société Générale|date=2012-04-13|website=Les Echos|language=fr|access-date=2020-02-04}}</ref> New York,<ref>{{cite web|url=http://www.americanbanker.com/issues/179_84/five-companies-to-watch-from-finovate-1067246-1.html|last=Wack|first=Kevin|title=Five Companies to Watch from Finovate|newspaper=[[American Banker]]|date=1 May 2014|access-date=4 February 2020}}</ref> [[Lyon]] and [[Bogota]]. Yseop was a pioneer in NLG which laid the groundwork for Chat [[ChatGPT|GPT]] and [[Generative AI]].{{Citation needed|reason=promotional tone; no evidence provided|date=December 2023}} Yseop's original founding team [https://nextstage-am.com/participations/yseop/ sold their stake in the company to Next Stage], a French Private Equity Company.
+As the world’s leading content automation solution for pharmaceuticals, Yseop Copilot is a digital colleague that empowers scientific writers and addresses the unique requirements of the highly regulated pharmaceutical industry. Blending the power of language models with customer data, Yseop Copilot delivers trusted and auditable content automation solutions in a closed, secure environment.
-== History ==
-Yseop was established in 2000 by Alain Kaeser, based on his research at the [[École normale supérieure Paris-Saclay]] (formerly ENS Cachan).{{citation needed|date=February 2020}} Research and development for Yseop's technology began in the mathematical lab [[École normale supérieure de Cachan]].<ref name=":0" />  The company was co-founded with John Rauscher, after he sold his start-up called Sunopsis to [[Oracle Corporation|Oracle]] in 2006.<ref name=":0" />
+With offices in Paris, New York and Lyon, the company has been at the forefront of the technological innovation that is reshaping regulated industries through [[Generative AI]] and automation.
-Yseop first commercialized its product as a [[middleware]] at the end of 2008, and opened up its American subsidiary in [[Dallas, Texas]] in 2012.<ref name=":2" />
 == The Yseop Team ==
+At the heart of Yseop's success is its dedicated team of professionals, including linguists and AI specialists. Led by CEO Emmanuel Walckenaer, the company is committed to promoting gender equality and diversity within its workforce. Yseop fosters a culture of innovation and collaboration, with a focus on delivering exceptional value to customers. Alain Kaeser, Yseop's founder, continues to lead its strategic planning.
-Former and current Yseop executives include Emmanuel Walckenaer (current CEO), John Rauscher (former CEO), Matthieu Andre (former CFO and currently at Groupe PSIH<ref>{{Cite web |title=Groupe PSIH - Mieux Comprendre, Mieux Décider, Mieux Soigner |url=https://groupepsih.com/ |access-date=2022-10-04 |website=Groupe PSIH |language=fr-FR}}</ref>), Maxine Azoulay (former US CTO and formerly of [[Meero]] and now at [[Airship (company)|Airship]]) and Arden Manning (formerly at the [[Democratic National Committee|DNC]] and currently cofounder of Nituno<ref>{{Cite web |title=About Us Nituno |url=https://www.nituno.com/about-us/ |access-date=2022-10-04 |website=Nituno |language=en-US}}</ref>). Alain Kaeser, Yseop's founder, has been with the company since 2000 and continues to lead its strategic planning.<ref>{{Cite web |title=Alain Kaeser {{!}} Yseop |url=https://www.yseop.com/people/alain-kaeser |access-date=2022-10-04 |website=www.yseop.com}}</ref>
 == Products ==
+Yseop launched Yseop Copilot, the world’s most secure content automation solution for regulated industries. Yseop Copilot is an enterprise software platform leveraging pre-trained LLM models for the BioPharma industry. The multimodal platform is a massive leap forward for life sciences firms looking to address their automation requirements and empowers scientific writers to be more strategic and productive with their resources in a closed, secure environment.
-Yseop commercializes [[natural language generation]] (NLG) software, which reasons on data and turns it into written recommendations and reports.<ref name=":2">{{Cite web|url=https://www.bizjournals.com/dallas/print-edition/2013/08/30/tech-titans-technology-inventor-yseop.html|title=Tech Titans Technology Inventor Award Finalist: Yseop Team|last=|first=|date=|website=www.bizjournals.com|archive-url=|archive-date=|access-date=2020-02-04}}</ref>
+Yseop Copilot supercharges productivity and keeps scientific writing in-house for quality control. With Yseop Copilot, scientific writers across hundreds of clinical trials have slashed writing times and improved the consistency and reliability of reports in record time. Yseop built this digital solution specifically for regulated industries like BioPharma, as proprietary prompts and validation methods ensure writing accuracy, while citations preserve traceability.
-Yseop's software writes in English, Spanish, French and German.<ref name=":1">{{Cite news|url=https://www.theguardian.com/technology/2014/sep/12/artificial-intelligence-data-journalism-media|title=The journalists who never sleep|last=Eudes|first=Yves|date=2014-09-12|work=The Guardian|access-date=2020-02-04|language=en-GB|issn=0261-3077}}</ref>
+Yseop Copilot is hosted in a fully secure, private environment for each customer. The multimodal platform leverages a variety of data-to-text (symbolic AI) and text-to-text (pre-trained open source LLM) techniques for the most cohesive and intelligent content automation process available to regulated industries today. GxP compliant with full auditability, users have control and pre-configured settings available for use right away. Yseop Copilot solves critical data security concerns and enables a high fidelity automation for non-clinical and clinical documents.
-Yseop has worked with [[Société Générale]].<ref name=":0" />
-== Recognition ==
+== Recognitions ==
+Yseop's dedication to innovation and customer satisfaction has earned it numerous accolades, including recognition from ChooseMyCompany for workplace happiness and motivation. The company is proud to be positioned in the Top 10 HappyIndex®AtWork for Startups + 50 employees in 2021, reflecting the enthusiasm and pride of its employees in democratizing NLG technology.
-In 2014, Tom Austin, vice president and fellow at [[Gartner]], cited Yseop, [[Narrative Science]] and [[Automated Insights]] as part of the Smart Machine, technological revolution that "has the promise to be one of the most disruptive changes ever".<ref>Tom Austin. Slideshare presentation, pages 48-55: http://www.gartner.com/it/content/2648000/2648016/february_13_smart_machine_taustin.pdf</ref><ref>{{Cite web|url=https://www.gartner.com/it/content/2648000/2648016/february_13_smart_machine_taustin.pdf|title=The Rise of the Smart Machines: Their Technical, Business, Economic and Social Impact|last=Austin|first=Tom|date=2014|website=Gartner|archive-url=|archive-date=|access-date=2020-02-04}}</ref>
+Yseop has since garnered significant recognition for its innovative contributions, winning prestigious awards and earning nominations across multiple categories. Among these achievements, Yseop has been honored as a winner and finalist in various esteemed competitions.
+In 2023:
+* Listed in The Top 10 [[natural language generation]] Companies in 2023 alongside Google and Open AI.
+* Shortlisted for Global Business Tech Awards as Tech Company of the Year in 2023. Yseop has been honored as a finalist as the Global Business Tech Awards showcase the best tech from around the world.
+* Nominated for World Technology Leader Awards. Yseop was in the company of prestigious nominees including OpenAI, BMW, and BASF. This award recognizes technology excellence across all industries and countries.
+* Winner at 2023 Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials. By winning Yseop platform “Yseop Copilot” has been recognized as a leading Generative AI solution, revolutionizing and improving drug discovery, clinical development, and the commercial adoption of new medicines.
+In 2024:
+* Shortlisted for Business Intelligence Group’s Artificial Intelligence Excellence Awards in 2024. Yseop has been honored as a where the award identifies and recognizes the truly unique solutions that stand out in a crowded artificial intelligence space.
+* Back-to-Back Finalists at Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials in 2024. has been named as a finalist for the second consecutive year at the 2024 Citeline Awards in the category of Best Use of Artificial Intelligence in Clinical Trials.
+== Yseop Podcast: AI Uncovered ==
+AI Uncovered is a podcast presented by Yseop for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries.
+With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across biopharmaceutical organizations. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.
 == See also ==